Dr. Jinny O. Tavee, MD

Dr. Tavee practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Tavee's NPI, 1437123940, was assigned on February 14, 2006. Dr. Tavee graduated from University of Missouri, Kansas City, School of Medicine in 1998. Dr. Tavee holds Colorado license 65135.

Dr. Tavee's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Tavee's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. Dr. Tavee is also affiliated with Saint Joseph Hospital. The medical group on file is National Jewish Health. Dmand AI also links Dr. Tavee to 2 more hospitals, each named with a free account. Dr. Tavee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tavee practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tavee's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Tavee's licenses on file in 2 states: Colorado and Illinois.

CMS data shows 361 Medicare services from Dr. Tavee across 6 procedure codes in 2024, for 168 Medicare patients. Medicare paid $31,796 for them.

CMS counts 168 Medicare patients who saw Dr. Tavee in 2024. The largest group is 65 to 74, with 74 patients. 72% of them have high cholesterol, and 71% have arthritis. 15% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tavee's median patient age at 68, with 62% women.

In 2024, Dr. Tavee wrote 527 Medicare Part D claims for 121 patients. 94% of them were for generic drugs. CMS names the drug for 348 of them, across 14 drugs with 11 or more claims each, at $661,443 in total drug cost. In 2023, CMS named 305 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Tavee for performance year 2024, reported as part of a group. Dr. Tavee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tavee as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Tavee, published from 2008 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Sarcoidosis, Diagnosis, Differential and Electromyography. Dr. Tavee has published most often in J Neurol Sci. Dr. Tavee's most frequent co-authors are Daniel A. Culver, DO, Robert P. Baughman, MD and Richard Joseph Nowak, MD.

Dmand AI links Dr. Tavee to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis, Sarcoidosis and Hypersensitivity, Delayed.

CMS Open Payments shows 53 general payments to Dr. Tavee from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. CSL Behring paid the most, $41,974.

Dr. Tavee graduated from University of Missouri, Kansas City, School of Medicine in 1998.